SI0881901T1 - New associations of active principles containing clopidogrel and an antithrombotic agent - Google Patents

New associations of active principles containing clopidogrel and an antithrombotic agent

Info

Publication number
SI0881901T1
SI0881901T1 SI9730355T SI9730355T SI0881901T1 SI 0881901 T1 SI0881901 T1 SI 0881901T1 SI 9730355 T SI9730355 T SI 9730355T SI 9730355 T SI9730355 T SI 9730355T SI 0881901 T1 SI0881901 T1 SI 0881901T1
Authority
SI
Slovenia
Prior art keywords
active principles
pct
antithrombotic agent
new associations
containing clopidogrel
Prior art date
Application number
SI9730355T
Other languages
English (en)
Slovenian (sl)
Inventor
Andre Bernat
Jean-Marc Herbert
Pierre Savi
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9489354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI0881901(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of SI0881901T1 publication Critical patent/SI0881901T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Materials For Medical Uses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI9730355T 1996-02-19 1997-02-17 New associations of active principles containing clopidogrel and an antithrombotic agent SI0881901T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9602027A FR2744918B1 (fr) 1996-02-19 1996-02-19 Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique
PCT/FR1997/000296 WO1997029753A1 (fr) 1996-02-19 1997-02-17 Nouvelles associations de principes actifs contenant du clopidogrel et un antithrombotique
EP97905218A EP0881901B1 (fr) 1996-02-19 1997-02-17 Nouvelles associations de principes actifs contenant du clopidogrel et un antithrombotique

Publications (1)

Publication Number Publication Date
SI0881901T1 true SI0881901T1 (en) 2002-10-31

Family

ID=9489354

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730355T SI0881901T1 (en) 1996-02-19 1997-02-17 New associations of active principles containing clopidogrel and an antithrombotic agent

Country Status (29)

Country Link
US (1) US5989578A (xx)
EP (1) EP0881901B1 (xx)
JP (1) JP3662028B2 (xx)
KR (1) KR100295345B1 (xx)
CN (1) CN1116042C (xx)
AT (1) ATE218870T1 (xx)
AU (1) AU715655B2 (xx)
BR (1) BR9707556A (xx)
CA (1) CA2246289C (xx)
CZ (1) CZ292363B6 (xx)
DE (2) DE69713287T2 (xx)
DK (1) DK0881901T3 (xx)
EE (1) EE03513B1 (xx)
ES (1) ES2176684T3 (xx)
FR (1) FR2744918B1 (xx)
HK (1) HK1017850A1 (xx)
HU (1) HU225036B1 (xx)
IL (1) IL125848A (xx)
IS (1) IS1892B (xx)
NO (2) NO317747B3 (xx)
NZ (1) NZ331444A (xx)
PL (1) PL187292B1 (xx)
PT (1) PT881901E (xx)
RU (1) RU2184547C2 (xx)
SI (1) SI0881901T1 (xx)
SK (1) SK284285B6 (xx)
TR (1) TR199801608T2 (xx)
UA (1) UA51695C2 (xx)
WO (1) WO1997029753A1 (xx)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2322824A1 (en) * 1998-03-13 1999-09-16 Merck & Co., Inc. Combination therapy and composition for acute coronary ischemic syndrome and related conditions
WO1999065500A1 (en) 1998-06-17 1999-12-23 Bristol-Myers Squibb Company Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
US6509348B1 (en) 1998-11-03 2003-01-21 Bristol-Myers Squibb Company Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
FR2792836B3 (fr) 1999-04-30 2001-07-27 Sanofi Sa Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
PL206138B1 (pl) * 2000-12-25 2010-07-30 Daiichi Sankyo Company Limiteddaiichi Sankyo Company Limited Kompozycja farmaceutyczna zawierająca aspirynę oraz zestaw i zastosowanie składników kompozycji
SE0101932D0 (sv) * 2001-05-31 2001-05-31 Astrazeneca Ab Pharmaceutical combinations
FR2832929A1 (fr) * 2001-12-05 2003-06-06 Sanofi Synthelabo Compositions pharmaceutiques contenant un agent antithrombotique et un derive d'amines cycliques
AU2003270861A1 (en) * 2002-10-02 2004-04-23 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
US20070243632A1 (en) * 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
ATE536889T1 (de) 2003-07-08 2011-12-15 Accumetrics Inc Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten
HUP0400982A2 (en) * 2004-05-17 2006-08-28 Chemor Kutato New veterinary product for honeybees
US20060222640A1 (en) * 2005-03-29 2006-10-05 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for treatment of thrombosis
EP1926736A4 (en) * 2005-09-21 2010-08-25 Chong Kun Dang Pharm Corp NEW RESINATE COMPLEX OF S-CLOPIDOGREL AND METHOD FOR THE PRODUCTION THEREOF
WO2008048083A1 (es) * 2006-10-17 2008-04-24 Espinosa Abdala Leopoldo De Je Composiciones farmacéuticas para el tratamiento de enfermedades tromboembólicas
DE102006051625A1 (de) 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
KR20160033792A (ko) 2007-04-27 2016-03-28 사이덱스 파마슈티칼스, 인크. 클로피도그렐 및 설포알킬 에테르 사이클로덱스트린을 함유하는 제형 및 사용 방법
KR100949273B1 (ko) * 2008-02-22 2010-03-25 한올제약주식회사 복합제제
DE102008032361A1 (de) * 2008-07-10 2010-01-21 Csl Behring Gmbh Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie
US8236782B2 (en) * 2009-05-13 2012-08-07 Cydex Pharmaceuticals, Inc. Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
EA021588B1 (ru) 2009-06-25 2015-07-30 Тетра Сиа Бетаиновые соли ацетилсалициловой кислоты
US8563574B2 (en) 2009-12-07 2013-10-22 Academic Pharmaceuticals, Inc. Parenteral formulation of clopidogrel
CN102389436A (zh) * 2011-09-09 2012-03-28 北京阜康仁生物制药科技有限公司 一种抗血小板聚集的药物组合物
KR101675501B1 (ko) * 2011-11-02 2016-11-14 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
US8513278B2 (en) 2011-11-26 2013-08-20 Academic Pharmaceuticals, Inc. Parenteral dextrose formulation of clopidogrel
CN102406938A (zh) * 2011-11-29 2012-04-11 北京阜康仁生物制药科技有限公司 一种抗血栓的药物组合物
WO2013133620A1 (en) * 2012-03-09 2013-09-12 Yuhan Corporation Pharmaceutical composition comprising clopidogrel and aspirin and process for preparing the same
CN103720700A (zh) * 2012-10-10 2014-04-16 江苏威凯尔医药科技有限公司 含有阿斯匹林和维卡格雷的药用组合物
EP2796145B1 (en) 2013-04-22 2017-11-01 CSL Ltd. A covalent complex of von willebrand factor and faktor viii linked by a disulphide bridge
KR101502588B1 (ko) 2013-05-01 2015-03-16 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
WO2015015062A1 (fr) * 2013-08-02 2015-02-05 Sanofi Comprime pharmaceutique comprenant de l'acide acetylsalicylique et du clopidogrel
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN107698620A (zh) * 2015-06-23 2018-02-16 江苏天士力帝益药业有限公司 一种氘代噻吩并哌啶衍生物、制备方法及其应用
RU2745774C1 (ru) * 2020-08-14 2021-03-31 Алексей Викторович Марочков Способ лечения пациентов с новой коронавирусной инфекцией (covid-19)
US20230059869A1 (en) 2021-08-03 2023-02-23 Liqmeds Worldwide Limited Oral pharmaceutical solution of clopidogrel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire

Also Published As

Publication number Publication date
PL327923A1 (en) 1999-01-04
NO2010015I1 (no) 2010-07-26
TR199801608T2 (xx) 1998-11-23
CA2246289C (fr) 2003-12-16
US5989578A (en) 1999-11-23
HUP9901144A2 (hu) 1999-09-28
NO983812L (no) 1998-10-09
ATE218870T1 (de) 2002-06-15
FR2744918A1 (fr) 1997-08-22
HU225036B1 (en) 2006-05-29
NO317747B3 (no) 2011-10-03
JP3662028B2 (ja) 2005-06-22
PT881901E (pt) 2002-09-30
DE69713287D1 (de) 2002-07-18
CN1211922A (zh) 1999-03-24
SK284285B6 (sk) 2005-01-03
DE122010000030I1 (de) 2010-10-21
DE122010000030I2 (de) 2012-06-21
PL187292B1 (pl) 2004-06-30
NO2010015I2 (no) 2012-11-12
SK110598A3 (en) 1999-01-11
JPH11510818A (ja) 1999-09-21
IL125848A (en) 2000-11-21
CN1116042C (zh) 2003-07-30
FR2744918B1 (fr) 1998-05-07
WO1997029753A1 (fr) 1997-08-21
HUP9901144A3 (en) 2001-04-28
AU1884497A (en) 1997-09-02
KR100295345B1 (ko) 2001-08-07
EE9800247A (et) 1999-02-15
BR9707556A (pt) 1999-07-27
CZ292363B6 (cs) 2003-09-17
HK1017850A1 (en) 1999-12-03
EP0881901A1 (fr) 1998-12-09
KR19990087163A (ko) 1999-12-15
DE69713287T2 (de) 2002-12-19
NO317747B1 (no) 2004-12-13
CA2246289A1 (fr) 1997-08-21
IS1892B (is) 2003-10-20
IL125848A0 (en) 1999-04-11
ES2176684T3 (es) 2002-12-01
RU2184547C2 (ru) 2002-07-10
CZ249998A3 (cs) 1998-11-11
EE03513B1 (et) 2001-10-15
EP0881901B1 (fr) 2002-06-12
DK0881901T3 (da) 2002-10-07
NO983812D0 (no) 1998-08-19
UA51695C2 (uk) 2002-12-16
NZ331444A (en) 2001-04-27
AU715655B2 (en) 2000-02-10
IS4827A (is) 1998-08-18

Similar Documents

Publication Publication Date Title
SI0881901T1 (en) New associations of active principles containing clopidogrel and an antithrombotic agent
CA2177772A1 (en) Pharmaceutical compositions containing irbesartan
HUP9900605A3 (en) Lipopolyamines as transfection agents, preparation and use thereof and pharmaceutical compositions containing them
HUP0200386A3 (en) Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity and pharmaceutical compositions containing them and their use
HUP9700005A3 (en) 2-ureido-benzamide derivatives and pharmaceutical compositions containing them as active agent
MX9706957A (es) Composicion que contiene amlodipina, o una sal, o felodipina y un inhibidor de enzima convertidora de angiotensina.
GEP20063719B (en) Prevention of Migraine Recurrence
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
ZA966047B (en) Therapeutic agents.
IL110724A0 (en) Retroviral protease inhibitors, their preparation and pharmaceutical compositions containing them
PL316079A1 (en) Antiussive composition containing an antitussive agent and benzidamine
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
BG106151A (en) Pharmaceutical complex
BG101849A (en) Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions
GB9802542D0 (en) New use
MY127527A (en) High-content famciclovir tablets
HUP0103623A2 (hu) Antitrombotikus hatású biszpiperidin vegyületek, előállítási eljárásuk és hatóanyagként ilyen vegyületeket tartalmazó gyógyszerkészítmények
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases
AU7533394A (en) Antiacid pharmaceutical composition in the form of a suspension based on sucralphate gel
PL301900A1 (en) Novel salt of 4-pyrimidinone derivatives, drug and pharmaceutical agent
AU2602988A (en) Contraceptive composition comprising nonoxynol-9, and d-propranolol or a pharmaceutically acceptable salt thereof
ZA942972B (en) New quinoxalinedione derivatives, their production and use in pharmaceutical agents.